AU1455292A - Soluble glucans - Google Patents

Soluble glucans

Info

Publication number
AU1455292A
AU1455292A AU14552/92A AU1455292A AU1455292A AU 1455292 A AU1455292 A AU 1455292A AU 14552/92 A AU14552/92 A AU 14552/92A AU 1455292 A AU1455292 A AU 1455292A AU 1455292 A AU1455292 A AU 1455292A
Authority
AU
Australia
Prior art keywords
soluble glucans
glucans
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14552/92A
Inventor
Nicholas R. Diluzio
Rose Mcnamee
David L Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioglucans LP
Original Assignee
Bioglucans LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US64952791A priority Critical
Priority to US649527 priority
Application filed by Bioglucans LP filed Critical Bioglucans LP
Publication of AU1455292A publication Critical patent/AU1455292A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y02A50/46Medical treatment of waterborne diseases characterized by the agent
    • Y02A50/468The waterborne disease being caused by a bacteria
    • Y02A50/473The waterborne disease being caused by a bacteria the bacteria being Escherichia coli, i.e. E. coli Infection
AU14552/92A 1991-02-01 1992-01-31 Soluble glucans Abandoned AU1455292A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US64952791A true 1991-02-01 1991-02-01
US649527 1991-02-01

Publications (1)

Publication Number Publication Date
AU1455292A true AU1455292A (en) 1992-09-07

Family

ID=24605186

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14552/92A Abandoned AU1455292A (en) 1991-02-01 1992-01-31 Soluble glucans

Country Status (2)

Country Link
AU (1) AU1455292A (en)
WO (1) WO1992013896A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5488040A (en) * 1989-09-08 1996-01-30 Alpha-Beta Technology, Inc. Use of neutral soluble glucan preparations to stimulate platelet production
AU650626B2 (en) * 1989-09-08 1994-06-30 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US5811542A (en) * 1989-09-08 1998-09-22 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
US5622940A (en) * 1994-07-14 1997-04-22 Alpha-Beta Technology Inhibition of infection-stimulated oral tissue destruction by β(1,3)-glucan
US6117850A (en) * 1995-08-28 2000-09-12 The Collaborative Group, Ltd. Mobilization of peripheral blood precursor cells by β(1,3)-glucan
US5786343A (en) * 1997-03-05 1998-07-28 Immudyne, Inc. Phagocytosis activator compositions and their use
US6046323A (en) * 1997-07-29 2000-04-04 The Collaborative Group, Ltd. Conformations of PPG-glucan
AU6261999A (en) 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
US6369216B1 (en) 1998-09-25 2002-04-09 Biopolymer Engineering Pharmaceutical, Inc. Very high molecular weight β-glucans
KR100717742B1 (en) * 1999-07-21 2007-05-11 가부시키가이샤 야쿠루트 혼샤 Cholesterol-lowering agents, secondary bile acid production inhibitors, and food and drinks
AU774978B2 (en) 1999-07-21 2004-07-15 Kabushiki Kaisha Yakult Honsha Cholesterol-lowering agents, secondary bile acid procuction inhibitors and foods and drinks
US6632459B2 (en) 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
LT6145B (en) 2014-04-14 2015-04-27 Uab "Biocentras" Therapeutic composition of beta-glucans modulating human immune system and initiating destruction of cancer cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985727A (en) * 1975-03-28 1976-10-12 Schering Corporation Aminoglycoside antibiotics
FR2447193B1 (en) * 1979-01-25 1981-12-11 Unicler
SE466289B (en) * 1984-09-19 1992-01-27 James Hoffman Macrophage Stimulating composition jaemte foerfarande foer its framstaellning
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
JPH0692441B2 (en) * 1986-03-03 1994-11-16 株式会社林原生物化学研究所 beta-D-glucan and its preparation and application

Also Published As

Publication number Publication date
WO1992013896A1 (en) 1992-08-20

Similar Documents

Publication Publication Date Title
AU643293B2 (en) Fall-arrest systems
AU653734C (en) Substituted 4-biphenylmethoxypyridine derivatives
AU653734B2 (en) Substituted 4-biphenylmethoxypyridine derivatives
AU639126B2 (en) Oxorapamycin
AU635147B2 (en) Transmitter
AU656958B2 (en) Substituted-2-phenyl-3-methoxypropenoates as fungicides
AU658898B2 (en) Substituted 3-aminoquinuclidines
AU663492B2 (en) Water soluble package
AU660321B2 (en) 1,2-dihydro-2-oxopyridine
AU647780B2 (en) CTMP-process
AU668526B2 (en) Enzyme-orthokeratology
AU659629B2 (en) N-acyl-alpha-amino acid derivatives
AU1959992A (en) 3-aryl-4-hydroxy-3-dihydrofuranone and 3-aryl-4-hydroxy- 3-dihydrothiophenone derivatives
AU1084492A (en) Dispenser
AU644249B2 (en) Alpha-oxoacetamide derivatives
AU3255593A (en) Dispenser
AU2096592A (en) 1-acylpiperidine compounds
AU1802492A (en) New aqueous formulations
AU1606992A (en) Water soluble film
AU4095397A (en) Novel glucan preparation
AU2012492A (en) Filter
AU1434192A (en) Article
AU2454992A (en) Dispersions
AU2013795A (en) Electronic-monetary system
AU3600193A (en) Nucleozymes